The briefing
A new report outlines lenacapavir, a long-acting antiretroviral that can be given as two injections a year, with each dose lasting up to six months. The piece describes how it could reduce reliance on daily pills for some patients.
Original headline
'One injection protects up to six months': what is new HIV drug lenacapavir?